EUVIMEDEUVIMED entdecken
CrossrefInfokarte

CD5L as a potential immunomodulator in dengue severity

Nurhafiza Zainal, Ni Luh Ayu Megasari, Chin Kim Ling, Lee Jiang Lin, Azwani Abdullah

Journal of Vector Borne Diseases · 2026-07 · 63 (3) · 383-389

DOI: 10.4103/jvbd.jvbd_223_25 ↗
AbstractBibliografische Angaben

Abstract

Background & objectives: CD5L (CD5 antigen-like) is a secreted glycoprotein involved in immune regulation, macrophage polarization, and lipid metabolism. While its role in inflammatory and bacterial diseases has been described, its function in viral infections such as dengue virus (DENV) infection remains unclear. This study aimed to evaluate serum CD5L levels in dengue-infected individuals and investigate its association with serological markers and disease severity. A cross-sectional study involving dengue-positive and dengue-negative individuals was conducted to compare serum CD5L concentrations and assess correlations with NS1, IgM, IgG status, and disease severity. Methods: Serum samples were collected from confirmed dengue-positive patients and dengue-negative controls. CD5L concentrations were quantified using enzyme-linked immunosorbent assay (ELISA) and analyzed according to serological profiles (NS1, IgM, and IgG). Two-group comparisons were performed using the Mann-Whitney U test, and multiple groups were analyzed using the Kruskal-Wallis test with Dunn’s post hoc test. A p-value

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →